A "genetic accelerator" is responsible for the most severe cases of Lupus (systemic lupus erythemathosus), an autoimmune disease: the accelerator, called enhancer HS1.2, speeds up the activity of some critical genes of the ...
Jan 16, 2012
0
0
The cost of one year's treatment of rheumatoid arthritis with new generation drugs is more than the per capita gross domestic product of 26 European countries, reveals research published online in the Annals of the Rheumatic ...
Mar 6, 2013
0
0
A clinical trial with 149 patients suffering from the very disabling autoimmune disease systemic lupus erythematosus, has shown the effectiveness of a synthetic peptide developed by a team of researchers led by CNRS biologist ...
Jan 25, 2013
0
1
Early, intensive therapy with a biotechnologically produced medication can provide significantly faster pain relief for patients with rheumatic joint inflammation. Damage to joints can also be reduced when the medication ...
Sep 27, 2012
0
0
A team led by the University of East Anglia (UEA) has made an advance in understanding the causes of adult-acquired flat feet – a painful condition particularly affecting middle-aged women.
Jan 12, 2012
0
0
